- Recent
- Popular
- Tags (1)
- Subscribers (7)
- Prometheus, $10M in Hand, Poised to Deliver Alternative Fuel for Shell Technology VenturesYesterday
-
Gregory T. Huang wrote:
Kirt Montague is the Comeback Kid of the Seattle cleantech community. We saw the fire in his eyes back in March when he rocked the room with a killer presentation on waste-to-energy at Xconomy’s cleantech forum in Seattle. And we see it again now that his company, Redmond, WA-based Prometheus Energy, which produces liquid natural gas from waste, has just closed $10 million in financing—with another $10 million to come upon reaching certain milestones—from Shell Technology Ventures Fund, which is managed by Netherlands-based Kenda Capital
- Happy Fireworks Day; See You Next WeekYesterday
-
Editors wrote:
When in the course of human events it becomes necessary for bloggers to temporarily dissolve the bonds which have connected them with their readers, and to assume among the powers of the earth the long weekend to which the laws of nature entitle them, a decent respect to the opinions of mankind requires that they should declare the causes which impel them to the separation. Simply put—and with apologies to Thomas Jefferson—we need a break.
So we’ll see you again on the 6th of July. If you’re looking for some reading material before then, we recommend the “Declaration of Innovation” penned earlier this week by Massachusetts’ Secretary Housing and Economic Development, Gregory Bialecki.
- Advertisement:July 2
-
- Google Voice Opening, SlowlyJuly 2
-
Wade Roush wrote:
Google Voice, a phone line unification and voice mail transcription service created by Grand Central and being revamped by Google, is gradually being opened up to people on its extensive waiting list, according to Twitter posts this week from the Google Voice team. “Still sending invites, many more today, but the list is long. Thx for your patience,” a post tonight read. Google began sending invitations to people on its reservations list on June 25. Xconomy reviewed Google Voice in March and published reviews from beta users in late June.
- Intellikine, Chasing Hot Cancer Drug Target, Raises Big Venture RoundJuly 2
-
Luke Timmerman wrote:
La Jolla, CA-based Intellikine, a company developing drugs against one of the hottest targets in cancer biology, has nailed down $16 million in venture capital out of a round that could be worth as much as $38.5 million, according to a regulatory filing.
Intellikine got the capital infusion from its founding crew of investors—Sofinnova Ventures, Abingworth Management, and CMEA Ventures—as well as four new investors, says David Kabakoff, an executive in residence with Sofinnova in San Diego.
The company, founded in September 2007, is developing drugs to block the PI3 kinase pathway, which controls critical cell processes like proliferation, migration, and cell survival. Evidence has been mounting for years that when these normal functions get flipped into an overactive mode, it’s a hallmark of cancer cells growing out of control